output stringlengths 5 24.3k | instruction stringlengths 33 308 | system stringclasses 1 value |
|---|---|---|
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Dyspnea [*drug therapy]; 3. Exercise Tolerance; 4. Morphine [adverse effects, therapeutic use]; 5. Palliative Care [*methods]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Terminal Care [*methods]; 9. Time Factors; 10. Walking; | Provide MESH terms for the study
Opioids for the palliation of refractory breathlessness in adults with advanced disease and terminal illness | You are a research assistant. Based on the question please provide appropriate answers |
1. Adenocarcinoma [*surgery]; 2. Carcinoma, Squamous Cell [*surgery]; 3. Diaphragm; 4. Esophageal Neoplasms [*surgery]; 5. Esophagectomy [adverse effects, *methods]; 6. Laparoscopy [*methods]; 7. Retrospective Studies; | Provide MESH terms for the study
Laparoscopic versus open transhiatal oesophagectomy for oesophageal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Exercise; 2. *Physical Fitness; 3. Antineoplastic Agents [therapeutic use]; 4. Body Mass Index; 5. Bone Density; 6. Controlled Clinical Trials as Topic; 7. Muscle Strength [physiology]; 8. Muscle, Skeletal [physiology]; 9. Neoplasms [therapy]; 10. Physical Endurance [physiology]; 11. Precursor Cell Lymphoblastic Leukemia‐Lymphoma [*drug therapy]; 12. Quality of Life; 13. Randomized Controlled Trials as Topic; 14. Range of Motion, Articular [physiology]; | Provide MESH terms for the study
Physical exercise training interventions for children and young adults during and after treatment for childhood cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Chemoradiotherapy [mortality]; 2. Esophageal Neoplasms [mortality, *therapy]; 3. Health Status; 4. Quality of Life; 5. Radiotherapy [mortality]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Non‐surgical versus surgical treatment for oesophageal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. Febrile Neutropenia [*chemically induced]; 3. *Length of Stay; 4. Neoplasms [*drug therapy]; 5. *Patient Discharge; 6. Randomized Controlled Trials as Topic; 7. *Standard of Care; 8. Time Factors; | Provide MESH terms for the study
Very early discharge versus early discharge versus non‐early discharge in children with cancer and febrile neutropenia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Pylorus; 2. Ampulla of Vater [*surgery]; 3. Blood Loss, Surgical; 4. Common Bile Duct Neoplasms [mortality, *surgery]; 5. Gastric Emptying; 6. Operative Time; 7. Organ Sparing Treatments [*methods]; 8. Pancreatic Fistula [etiology]; 9. Pancreatic Neoplasms [mortality, *surgery]; 10. Pancreaticoduodenectomy [adverse effects, *methods, mortality]; 11. Quality of Life; 12. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pylorus‐preserving pancreaticoduodenectomy (pp Whipple) versus pancreaticoduodenectomy (classic Whipple) for surgical treatment of periampullary and pancreatic carcinoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Alopecia [chemically induced]; 2. Antimetabolites, Antineoplastic [adverse effects, therapeutic use]; 3. Antineoplastic Agents, Phytogenic [adverse effects, therapeutic use]; 4. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 5. Camptothecin [administration & dosage, adverse effects, analogs & derivatives]; 6. Colorectal Neoplasms [*drug therapy, mortality, pathology]; 7. Diarrhea [chemically induced]; 8. Disease-Free Survival; 9. Fluorouracil [administration & dosage, adverse effects]; 10. Irinotecan; 11. Nausea [chemically induced]; 12. Neutropenia; 13. Quality of Life; 14. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Irinotecan chemotherapy combined with fluoropyrimidines versus irinotecan alone for overall survival and progression‐free survival in patients with advanced and/or metastatic colorectal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Critical Pathways; 2. *Terminal Care [psychology]; 3. Dyspnea [prevention & control]; 4. Nausea [prevention & control]; 5. Pain Management; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Treatment Outcome; 9. Vomiting [prevention & control]; | Provide MESH terms for the study
End‐of‐life care pathways for improving outcomes in caring for the dying | You are a research assistant. Based on the question please provide appropriate answers |
1. Deglutition Disorders [*complications]; 2. Enteral Nutrition [*methods]; 3. Gastrostomy [*methods]; | Provide MESH terms for the study
Percutaneous endoscopic gastrostomy versus percutaneous radiological gastrostomy for swallowing disturbances | You are a research assistant. Based on the question please provide appropriate answers |
1. Antiemetics [adverse effects, *therapeutic use]; 2. Antineoplastic Agents [*adverse effects]; 3. Dexamethasone [therapeutic use]; 4. Drug Therapy, Combination [adverse effects, methods]; 5. Nausea [chemically induced, *drug therapy, *prevention & control]; 6. Neoplasms [drug therapy]; 7. Randomized Controlled Trials as Topic; 8. Serotonin Antagonists [adverse effects, therapeutic use]; 9. Vomiting [chemically induced, *drug therapy, *prevention & control]; | Provide MESH terms for the study
Antiemetic medication for prevention and treatment of chemotherapy‐induced nausea and vomiting in childhood | You are a research assistant. Based on the question please provide appropriate answers |
1. Antifibrinolytic Agents [*therapeutic use]; 2. Blood Loss, Surgical [*prevention & control, statistics & numerical data]; 3. Blood Transfusion [statistics & numerical data]; 4. Cytoreduction Surgical Procedures [adverse effects, *methods]; 5. Erythrocyte Transfusion [*statistics & numerical data]; 6. Incidence; 7. Ovarian Neoplasms [pathology, *surgery]; 8. Patient Readmission [statistics & numerical data]; 9. Plasma; 10. Randomized Controlled Trials as Topic; 11. Reoperation [statistics & numerical data]; 12. Thromboembolism [epidemiology]; 13. Tranexamic Acid [*therapeutic use]; | Provide MESH terms for the study
Effectiveness of tranexamic acid in reducing blood loss during cytoreductive surgery for advanced ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Drug Resistance, Neoplasm; 2. Gestational Trophoblastic Disease [*drug therapy]; 3. Neoplasm Recurrence, Local [*drug therapy]; | Provide MESH terms for the study
Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*administration & dosage, adverse effects]; 2. Disease-Free Survival; 3. Induction Chemotherapy [adverse effects, *methods]; 4. Infusions, Intravenous; 5. Infusions, Parenteral [adverse effects, *methods]; 6. Ovarian Neoplasms [*drug therapy, mortality]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*therapeutic use]; 2. Chemotherapy, Adjuvant [mortality]; 3. Combined Modality Therapy [methods]; 4. Induction Chemotherapy [mortality]; 5. Neoadjuvant Therapy [methods, mortality]; 6. Ovarian Neoplasms [*drug therapy, mortality, pathology, *surgery]; 7. Quality of Life; 8. Randomized Controlled Trials as Topic; 9. Survival Rate; 10. Tumor Burden [drug effects]; | Provide MESH terms for the study
Interval debulking surgery for advanced epithelial ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Fiducial Markers; 2. Breast Neoplasms [*diagnosis, pathology, *surgery]; 3. Iodine Radioisotopes; 4. Palpation; 5. Randomized Controlled Trials as Topic; 6. Tumor Burden; | Provide MESH terms for the study
Localization techniques for guided surgical excision of non‐palpable breast lesions | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*therapeutic use]; 2. Carboplatin [therapeutic use]; 3. Chemotherapy, Adjuvant [methods]; 4. Cisplatin [therapeutic use]; 5. Disease‐Free Survival; 6. Early Detection of Cancer; 7. Melphalan [therapeutic use]; 8. Neoplasm Staging; 9. Ovarian Neoplasms [*drug therapy, pathology, surgery]; 10. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Adjuvant (post‐surgery) chemotherapy for early stage epithelial ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibodies, Monoclonal, Humanized [therapeutic use]; 2. Antineoplastic Agents [*therapeutic use]; 3. Carcinoma, Squamous Cell [mortality, *therapy]; 4. Cetuximab [therapeutic use]; 5. Cisplatin [therapeutic use]; 6. Docetaxel; 7. ErbB Receptors; 8. Gefitinib; 9. Immunotherapy [adverse effects, *methods]; 10. Lapatinib; 11. Molecular Targeted Therapy [adverse effects, *methods]; 12. Mouth Neoplasms [mortality, *therapy]; 13. Oropharyngeal Neoplasms [mortality, *therapy]; 14. Protein Kinase Inhibitors [therapeutic use]; 15. Protein‐Tyrosine Kinases [antagonists & inhibitors]; 16. Quinazolines [therapeutic use]; 17. Randomized Controlled Trials as Topic; 18. Taxoids [therapeutic use]; | Provide MESH terms for the study
Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Antiemetics [adverse effects, *therapeutic use]; 2. Antineoplastic Agents [adverse effects]; 3. Cannabinoids [adverse effects, *therapeutic use]; 4. Chlorpromazine [adverse effects, therapeutic use]; 5. Dizziness [chemically induced]; 6. Domperidone [adverse effects, therapeutic use]; 7. Euphoria; 8. Metoclopramide [adverse effects, therapeutic use]; 9. Nausea [chemically induced, *drug therapy]; 10. Neoplasms [*drug therapy]; 11. Prochlorperazine [adverse effects, therapeutic use]; 12. Randomized Controlled Trials as Topic; 13. Vomiting [chemically induced, *drug therapy]; | Provide MESH terms for the study
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Surgical Instruments; 2. *Surgical Staplers; 3. *Suture Techniques; 4. Fibrin Tissue Adhesive; 5. Operative Time; 6. Pancreas [*surgery]; 7. Pancreatectomy [adverse effects, *methods, mortality]; 8. Pancreatic Fistula [epidemiology, etiology]; 9. Randomized Controlled Trials as Topic; 10. Surgical Mesh; | Provide MESH terms for the study
Stapler versus scalpel resection followed by hand‐sewn closure of the pancreatic remnant for distal pancreatectomy | You are a research assistant. Based on the question please provide appropriate answers |
1. *Palliative Care; 2. Antiemetics [adverse effects, *therapeutic use]; 3. Methotrimeprazine [adverse effects, *therapeutic use]; 4. Nausea [*drug therapy]; 5. Vomiting [*drug therapy]; | Provide MESH terms for the study
Levomepromazine for nausea and vomiting in palliative care | You are a research assistant. Based on the question please provide appropriate answers |
1. Antiemetics [*therapeutic use]; 2. Diphenhydramine [therapeutic use]; 3. Gels; 4. Haloperidol [*therapeutic use]; 5. Lorazepam [therapeutic use]; 6. Nausea [*drug therapy]; 7. *Palliative Care; 8. Randomized Controlled Trials as Topic; 9. Vomiting [*drug therapy]; | Provide MESH terms for the study
Haloperidol for the treatment of nausea and vomiting in palliative care patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [adverse effects, *therapeutic use]; 2. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 3. Carboplatin [therapeutic use]; 4. Carcinoma, Non‐Small‐Cell Lung [*drug therapy, mortality, pathology]; 5. Cisplatin [therapeutic use]; 6. Lung Neoplasms [*drug therapy, mortality, pathology]; 7. Platinum Compounds [*therapeutic use]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Chemotherapy for advanced non‐small cell lung cancer in the elderly population | You are a research assistant. Based on the question please provide appropriate answers |
1. Acupuncture Therapy [*methods]; 2. Acupuncture, Ear [methods]; 3. Neoplasms [*complications]; 4. Pain [etiology]; 5. Pain Management [*methods]; 6. Pain Measurement; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Acupuncture for cancer pain in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Antineoplastic Combined Chemotherapy Protocols [*administration & dosage, adverse effects]; 3. Bone Marrow [drug effects]; 4. Disease‐Free Survival; 5. Hematopoietic Stem Cell Transplantation [*methods, mortality]; 6. Neoplasm Recurrence, Local; 7. Neuroblastoma [mortality, *therapy]; 8. Prognosis; 9. Randomized Controlled Trials as Topic; 10. Salvage Therapy [methods]; | Provide MESH terms for the study
High‐dose chemotherapy and autologous haematopoietic stem cell rescue for children with high‐risk neuroblastoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents, Alkylating [*therapeutic use]; 2. Bone Neoplasms [*drug therapy]; 3. Cyclophosphamide [*therapeutic use]; 4. Ifosfamide [*therapeutic use]; 5. Sarcoma [*drug therapy]; 6. Soft Tissue Neoplasms [*drug therapy]; | Provide MESH terms for the study
Cyclophosphamide versus ifosfamide for paediatric and young adult bone and soft tissue sarcoma patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Neoplasms [*complications]; 2. Pain [*drug therapy]; 3. Phenols [*therapeutic use]; 4. Randomized Controlled Trials as Topic; 5. Receptors, Opioid, mu [*therapeutic use]; 6. Tapentadol; | Provide MESH terms for the study
Oral tapentadol for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Enteral Nutrition [*methods]; 2. Leukemia [drug therapy]; 3. Malnutrition [etiology, *therapy]; 4. Neoplasms [*drug therapy]; 5. Parenteral Nutrition [*methods]; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Nutritional support in children and young people with cancer undergoing chemotherapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Anal Canal; 2. Brain Neoplasms [*rehabilitation, therapy]; 3. Combined Modality Therapy [methods]; 4. Controlled Clinical Trials as Topic; 5. Locomotion; 6. Quality of Life; 7. Social Participation; | Provide MESH terms for the study
Multidisciplinary rehabilitation after primary brain tumour treatment | You are a research assistant. Based on the question please provide appropriate answers |
1. *Spinal Cord Stimulation [adverse effects]; 2. Analgesics, Opioid [administration & dosage]; 3. Cerebrospinal Fluid Leak [etiology]; 4. Checklist; 5. Controlled Before‐After Studies; 6. Neoplasms [*complications]; 7. Pain [*etiology]; 8. Pain Management [adverse effects, *methods]; 9. Pain Measurement; | Provide MESH terms for the study
Spinal cord stimulation for cancer‐related pain in adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents, Hormonal [*therapeutic use]; 2. Antineoplastic Agents, Phytogenic [*therapeutic use]; 3. Breast Neoplasms [*drug therapy, mortality, pathology]; 4. Bridged‐Ring Compounds [therapeutic use]; 5. Disease Progression; 6. Paclitaxel [therapeutic use]; 7. Randomized Controlled Trials as Topic; 8. Tamoxifen [therapeutic use]; 9. Taxoids [*therapeutic use]; | Provide MESH terms for the study
Taxane‐containing regimens for metastatic breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Amantadine [therapeutic use]; 2. Benzhydryl Compounds [therapeutic use]; 3. Carnitine [therapeutic use]; 4. Central Nervous System Stimulants [therapeutic use]; 5. Chronic Disease; 6. Fatigue [*drug therapy, etiology]; 7. Kidney Failure, Chronic [complications]; 8. Methylphenidate [therapeutic use]; 9. Modafinil; 10. Multiple Sclerosis [complications]; 11. Neoplasms [complications]; 12. *Palliative Care; 13. Pemoline [therapeutic use]; 14. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pharmacological treatments for fatigue associated with palliative care | You are a research assistant. Based on the question please provide appropriate answers |
1. Deglutition Disorders [*complications]; 2. Enteral Nutrition [*methods, mortality]; 3. Gastrostomy [adverse effects, *methods, mortality]; 4. Intubation, Gastrointestinal [adverse effects, methods, mortality]; 5. Malnutrition [etiology, *therapy]; 6. Pneumonia [etiology]; 7. Randomized Controlled Trials as Topic; 8. Treatment Failure; | Provide MESH terms for the study
Percutaneous endoscopic gastrostomy versus nasogastric tube feeding for adults with swallowing disturbances | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [administration & dosage, adverse effects, *therapeutic use]; 2. Carboplatin [administration & dosage, adverse effects]; 3. Cisplatin [administration & dosage, adverse effects]; 4. Cyclophosphamide [administration & dosage, adverse effects]; 5. Drug Administration Schedule; 6. Etoposide [administration & dosage, adverse effects]; 7. Induction Chemotherapy [adverse effects, *methods]; 8. Neuroblastoma [*drug therapy]; 9. Randomized Controlled Trials as Topic; 10. Vincristine [administration & dosage, adverse effects]; | Provide MESH terms for the study
Rapid COJEC versus standard induction therapies for high‐risk neuroblastoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Antitussive Agents [therapeutic use]; 2. Brachytherapy [methods]; 3. Cough [etiology, *therapy]; 4. Drugs, Chinese Herbal [therapeutic use]; 5. Laser Therapy [methods]; 6. Neoplasms [*complications, therapy]; 7. Photochemotherapy [methods]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Interventions for cough in cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Disease-Free Survival; 2. *Lymph Node Excision; 3. Melanoma [mortality, *pathology, *surgery]; 4. Melanoma, Cutaneous Malignant; 5. Randomized Controlled Trials as Topic; 6. *Sentinel Lymph Node Biopsy; 7. Skin Neoplasms [mortality, *pathology, *surgery]; 8. Survival Rate; 9. Watchful Waiting; | Provide MESH terms for the study
Sentinel lymph node biopsy followed by lymph node dissection for localised primary cutaneous melanoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics, Opioid [adverse effects]; 2. Anthraquinones [therapeutic use]; 3. Cathartics [adverse effects, *therapeutic use]; 4. Constipation [chemically induced, *drug therapy]; 5. Lactulose [therapeutic use]; 6. Magnesium Hydroxide [therapeutic use]; 7. Naltrexone [adverse effects, *analogs & derivatives, therapeutic use]; 8. *Palliative Care; 9. Paraffin [therapeutic use]; 10. Quaternary Ammonium Compounds [adverse effects, therapeutic use]; 11. Randomized Controlled Trials as Topic; 12. Senna Extract [therapeutic use]; | Provide MESH terms for the study
Laxatives for the management of constipation in people receiving palliative care | You are a research assistant. Based on the question please provide appropriate answers |
1. Amygdalin [adverse effects, *therapeutic use]; 2. Antineoplastic Agents, Phytogenic [adverse effects, *therapeutic use]; 3. Neoplasms [*drug therapy]; | Provide MESH terms for the study
Laetrile treatment for cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Cutaneous; 2. Administration, Oral; 3. Administration, Sublingual; 4. Analgesics, Opioid [administration & dosage, *therapeutic use]; 5. Buprenorphine [administration & dosage, *therapeutic use]; 6. Neoplasms [*complications]; 7. Pain [*drug therapy, etiology]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Buprenorphine for treating cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. *Chewing Gum; 2. Abdomen [surgery]; 3. Gastrointestinal Motility [*physiology]; 4. Ileus [*therapy]; 5. Length of Stay; 6. Postoperative Complications [*therapy]; 7. Postoperative Period; 8. Randomized Controlled Trials as Topic; 9. Recovery of Function [*physiology]; 10. Time Factors; | Provide MESH terms for the study
Chewing gum for postoperative recovery of gastrointestinal function | You are a research assistant. Based on the question please provide appropriate answers |
1. *Patient Education as Topic; 2. Breast Neoplasms [*therapy]; 3. Drainage [*methods]; 4. Exercise Therapy [*methods]; 5. Lymphedema [*prevention & control]; 6. Quality of Life; 7. Randomized Controlled Trials as Topic; 8. Range of Motion, Articular; 9. Resistance Training [*methods]; 10. Shoulder Joint [physiopathology]; | Provide MESH terms for the study
Conservative interventions for preventing clinically detectable upper‐limb lymphoedema in patients who are at risk of developing lymphoedema after breast cancer therapy | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetic Acid [*administration & dosage, adverse effects]; 2. Administration, Cutaneous; 3. Antineoplastic Agents [*administration & dosage, adverse effects]; 4. Carcinoma, Hepatocellular [*drug therapy, pathology, surgery]; 5. Catheter Ablation [methods]; 6. Ethanol [*administration & dosage, adverse effects]; 7. Liver Neoplasms [*drug therapy, pathology, surgery]; 8. Randomized Controlled Trials as Topic; 9. Tumor Burden; | Provide MESH terms for the study
Percutaneous ethanol injection or percutaneous acetic acid injection for early hepatocellular carcinoma | You are a research assistant. Based on the question please provide appropriate answers |
1. *Palliative Care; 2. Carcinoma, Non‐Small‐Cell Lung [mortality, *radiotherapy]; 3. Lung Neoplasms [mortality, *radiotherapy]; 4. Radiotherapy Dosage; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Palliative radiotherapy regimens for patients with thoracic symptoms from non‐small cell lung cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Body Image; 2. Breast Neoplasms [*psychology, *rehabilitation]; 3. Dance Therapy [methods]; 4. Depression [*rehabilitation]; 5. Exercise Movement Techniques [*methods, psychology]; 6. Fatigue [*rehabilitation]; 7. Neoplasms [psychology, rehabilitation]; 8. Quality of Life; 9. Randomized Controlled Trials as Topic; 10. Self Concept; 11. Standard of Care; | Provide MESH terms for the study
Dance/movement therapy for improving psychological and physical outcomes in cancer patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Neoplasm Recurrence, Local [*diagnosis, virology]; 2. Neoplasm, Residual; 3. Papillomaviridae; 4. Papillomavirus Infections [*diagnosis]; 5. Uterine Cervical Dysplasia [*diagnosis, surgery]; 6. Uterine Cervical Neoplasms [*diagnosis, surgery, virology]; | Provide MESH terms for the study
Follow‐up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test | You are a research assistant. Based on the question please provide appropriate answers |
1. Abdominal Neoplasms [*surgery]; 2. Laparoscopy; 3. Laparotomy; 4. Thoracic Neoplasms [*surgery]; 5. Thoracoscopy; 6. Thoracotomy; | Provide MESH terms for the study
Minimally invasive surgery versus open surgery for the treatment of solid abdominal and thoracic neoplasms in children | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 2. Cerebellar Neoplasms [*drug therapy, mortality, radiotherapy]; 3. Disease‐Free Survival; 4. Medulloblastoma [*drug therapy, mortality, radiotherapy]; 5. Radiotherapy Dosage; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Chemotherapy for children with medulloblastoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 2. Chemoradiotherapy [*methods, mortality]; 3. Chemotherapy, Adjuvant [adverse effects, methods, mortality]; 4. Cisplatin [administration & dosage]; 5. Deoxycytidine [administration & dosage, analogs & derivatives]; 6. Fluorouracil [administration & dosage]; 7. Mitomycin [administration & dosage]; 8. Neoplasm Staging; 9. Randomized Controlled Trials as Topic; 10. Uterine Cervical Neoplasms [mortality, pathology, *therapy]; | Provide MESH terms for the study
Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Enterochromaffin‐like Cells [pathology]; 2. Gastritis, Atrophic [chemically induced]; 3. Hyperplasia [chemically induced]; 4. Intestines [pathology]; 5. Maintenance Chemotherapy [adverse effects]; 6. Metaplasia [chemically induced]; 7. Precancerous Conditions [*chemically induced, pathology]; 8. Proton Pump Inhibitors [*adverse effects]; 9. Randomized Controlled Trials as Topic; 10. Stomach Neoplasms [*chemically induced, pathology]; 11. Time Factors; | Provide MESH terms for the study
Long‐term proton pump inhibitor (PPI) use and the development of gastric pre‐malignant lesions | You are a research assistant. Based on the question please provide appropriate answers |
1. Antiemetics [adverse effects, *therapeutic use]; 2. Droperidol [adverse effects, *therapeutic use]; 3. Nausea [*drug therapy]; 4. *Palliative Care; 5. Terminal Care; 6. Vomiting [*drug therapy]; | Provide MESH terms for the study
Droperidol for treatment of nausea and vomiting in palliative care patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Adenocarcinoma [drug therapy, mortality, pathology]; 2. Antibodies, Monoclonal, Humanized [*therapeutic use]; 3. Antineoplastic Agents [*therapeutic use]; 4. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 5. Carcinoma, Non‐Small‐Cell Lung [*drug therapy, mortality, pathology]; 6. Cetuximab; 7. Disease‐Free Survival; 8. Lung Neoplasms [*drug therapy, mortality, pathology]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Chemotherapy with cetuximab versus chemotherapy alone for chemotherapy‐naive advanced non‐small cell lung cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Anti-Bacterial Agents [therapeutic use]; 2. Chemotherapy-Induced Febrile Neutropenia [*drug therapy]; 3. Colony-Stimulating Factors [therapeutic use]; 4. Drug Therapy, Combination; 5. Fever [chemically induced, drug therapy]; 6. Granulocyte Colony-Stimulating Factor [*therapeutic use]; 7. Granulocyte-Macrophage Colony-Stimulating Factor [*therapeutic use]; 8. Neoplasms [drug therapy]; 9. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Colony‐stimulating factors for chemotherapy‐induced febrile neutropenia | You are a research assistant. Based on the question please provide appropriate answers |
1. Brachytherapy [*methods]; 2. Neoplasm Recurrence, Local; 3. Neoplasm Staging; 4. Radiotherapy Dosage; 5. Randomized Controlled Trials as Topic; 6. Uterine Cervical Neoplasms [mortality, pathology, *radiotherapy]; | Provide MESH terms for the study
High dose rate versus low dose rate intracavity brachytherapy for locally advanced uterine cervix cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Acetaminophen [adverse effects, *therapeutic use]; 2. Analgesics, Non‐Narcotic [adverse effects, *therapeutic use]; 3. Analgesics, Opioid [adverse effects, *therapeutic use]; 4. Codeine [adverse effects, *therapeutic use]; 5. Drug Therapy, Combination [adverse effects, methods]; 6. Neoplasms [*complications]; 7. Pain [*drug therapy, etiology]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Codeine, alone and with paracetamol (acetaminophen), for cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Anthracyclines [adverse effects, *therapeutic use]; 2. Antibiotics, Antineoplastic [adverse effects, *therapeutic use]; 3. Bone Neoplasms [drug therapy]; 4. Heart Diseases [chemically induced]; 5. Hepatoblastoma [drug therapy]; 6. Kidney Neoplasms [drug therapy]; 7. Leukemia, Myeloid, Acute [drug therapy]; 8. Liver Neoplasms [drug therapy]; 9. Lymphoma, Non‐Hodgkin [drug therapy]; 10. Neoplasms [*drug therapy]; 11. Precursor Cell Lymphoblastic Leukemia‐Lymphoma [drug therapy]; 12. Randomized Controlled Trials as Topic; 13. Sarcoma [drug therapy]; 14. Wilms Tumor [drug therapy]; | Provide MESH terms for the study
Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Antiretroviral Therapy, Highly Active; 2. Alitretinoin; 3. Antineoplastic Agents [*therapeutic use]; 4. Bleomycin [administration & dosage]; 5. Doxorubicin [administration & dosage]; 6. Drug Therapy, Combination; 7. Etoposide [administration & dosage]; 8. HIV Infections [*complications, drug therapy]; 9. Liposomes; 10. Observational Studies as Topic; 11. Randomized Controlled Trials as Topic; 12. Sarcoma, Kaposi [*drug therapy, virology]; 13. Skin Neoplasms [*drug therapy, virology]; 14. Tretinoin [therapeutic use]; 15. Vincristine [administration & dosage]; | Provide MESH terms for the study
Treatment of severe or progressive Kaposi's sarcoma in HIV‐infected adults | You are a research assistant. Based on the question please provide appropriate answers |
1. Androgen Antagonists [adverse effects, *therapeutic use]; 2. Anilides [adverse effects, therapeutic use]; 3. Antineoplastic Agents, Hormonal [adverse effects, *therapeutic use]; 4. Disease Progression; 5. Flutamide [adverse effects, therapeutic use]; 6. Gonadotropin‐Releasing Hormone [adverse effects, *therapeutic use]; 7. Goserelin [adverse effects, therapeutic use]; 8. Leuprolide [adverse effects, therapeutic use]; 9. Medication Adherence [statistics & numerical data]; 10. Nitriles [adverse effects, therapeutic use]; 11. Orchiectomy [*methods, mortality]; 12. Prostatic Neoplasms [mortality, pathology, *therapy]; 13. Randomized Controlled Trials as Topic; 14. Tosyl Compounds [adverse effects, therapeutic use]; 15. Triptorelin Pamoate [adverse effects, therapeutic use]; | Provide MESH terms for the study
Non‐steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Analgesics, Opioid [adverse effects, *therapeutic use]; 2. Appetite [*drug effects]; 3. Codeine [adverse effects, therapeutic use]; 4. Consciousness [*drug effects]; 5. Fentanyl [adverse effects, therapeutic use]; 6. Morphine [adverse effects, therapeutic use]; 7. Neoplasms [*complications]; 8. Oxycodone [adverse effects, therapeutic use]; 9. Pain [*drug therapy, etiology]; 10. Randomized Controlled Trials as Topic; 11. Terminal Care; 12. Thirst [*drug effects]; | Provide MESH terms for the study
Impact of morphine, fentanyl, oxycodone or codeine on patient consciousness, appetite and thirst when used to treat cancer pain | You are a research assistant. Based on the question please provide appropriate answers |
1. Neoplasm Staging; 2. Uterine Cervical Neoplasms [pathology, *surgery]; | Provide MESH terms for the study
Surgical treatment of stage IA2 cervical cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents, Hormonal [*therapeutic use]; 2. Breast Neoplasms [*drug therapy, *surgery]; 3. Combined Modality Therapy; 4. Randomized Controlled Trials as Topic; 5. Tamoxifen [*therapeutic use]; | Provide MESH terms for the study
Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus) | You are a research assistant. Based on the question please provide appropriate answers |
1. Astrocytoma [*drug therapy, *radiotherapy, surgery]; 2. Brain Neoplasms [*drug therapy, *radiotherapy, surgery]; 3. Chemotherapy, Adjuvant; 4. Oligodendroglioma [*drug therapy, *radiotherapy, surgery]; 5. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Adjuvant treatment of anaplastic oligodendrogliomas and oligoastrocytomas | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 2. Chemoradiotherapy; 3. Chemotherapy, Adjuvant [adverse effects, methods, mortality]; 4. Cisplatin [administration & dosage]; 5. Disease-Free Survival; 6. Doxorubicin [administration & dosage]; 7. Endometrial Neoplasms [*drug therapy, mortality, pathology, therapy]; 8. Neoplasm Staging; 9. Paclitaxel [administration & dosage]; 10. Radiotherapy, Adjuvant; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Adjuvant chemotherapy for advanced endometrial cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Enteral Nutrition [adverse effects, methods]; 2. *Parenteral Nutrition [adverse effects, methods]; 3. Longevity; 4. Palliative Care [*methods]; 5. Quality of Life; | Provide MESH terms for the study
Medically assisted nutrition for adult palliative care patients | You are a research assistant. Based on the question please provide appropriate answers |
1. *Laparoscopy; 2. Conversion to Open Surgery [statistics & numerical data]; 3. Elective Surgical Procedures; 4. Rectal Neoplasms [*surgery]; 5. Rectum [*surgery]; 6. Treatment Outcome; | Provide MESH terms for the study
Laparoscopic versus open total mesorectal excision for rectal cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Carcinoma in Situ [pathology, *surgery]; 2. Lasers, Gas [*therapeutic use]; 3. Precancerous Conditions [pathology, *surgery]; 4. Randomized Controlled Trials as Topic; 5. Suction [methods]; 6. Ultrasonic Therapy [instrumentation, *methods]; 7. Vulvar Neoplasms [pathology, *surgery]; | Provide MESH terms for the study
Surgical interventions for high‐grade vulval intraepithelial neoplasia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Radiosurgery; 2. Brain Neoplasms [mortality, *radiotherapy, secondary, *surgery]; 3. Combined Modality Therapy [methods]; 4. Cranial Irradiation [*methods]; 5. Disease‐Free Survival; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Surgery or radiosurgery plus whole brain radiotherapy versus surgery or radiosurgery alone for brain metastases | You are a research assistant. Based on the question please provide appropriate answers |
1. Chemoradiotherapy, Adjuvant; 2. Immunotherapy [methods]; 3. Lymph Node Excision; 4. Palliative Care [*methods]; 5. Pancreas [blood supply, *surgery]; 6. Pancreatectomy [methods]; 7. Pancreatic Neoplasms [blood supply, mortality, *therapy]; 8. Pancreaticoduodenectomy [methods]; 9. Randomized Controlled Trials as Topic; 10. Splenectomy; 11. Survival Rate; | Provide MESH terms for the study
Resection versus other treatments for locally advanced pancreatic cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Carcinoma, Squamous Cell [*therapy, *virology]; 2. Clinical Protocols; 3. Oropharyngeal Neoplasms [*therapy, *virology]; 4. Papillomavirus Infections [complications, *therapy]; 5. Prospective Studies; 6. Systematic Reviews as Topic; | Provide MESH terms for the study
De‐escalation treatment protocols for human papillomavirus‐associated oropharyngeal squamous cell carcinoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Genital Neoplasms, Female [pathology, *surgery]; 2. Neoplasm Recurrence, Local [*surgery]; 3. Pelvic Exenteration; | Provide MESH terms for the study
Exenterative surgery for recurrent gynaecological malignancies | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*administration & dosage, adverse effects]; 2. Antineoplastic Combined Chemotherapy Protocols [*administration & dosage, adverse effects]; 3. Breast Neoplasms [*drug therapy, mortality, pathology]; 4. Disease Progression; 5. Disease-Free Survival; 6. Nausea [chemically induced]; 7. Neutropenia [chemically induced]; 8. Randomized Controlled Trials as Topic; 9. Vomiting [chemically induced]; | Provide MESH terms for the study
Combination versus sequential single agent chemotherapy for metastatic breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 2. Carcinoma, Small Cell [*drug therapy, mortality, pathology]; 3. Doxorubicin [administration & dosage]; 4. Lung Neoplasms [*drug therapy, mortality, pathology]; 5. Methotrexate [administration & dosage]; 6. Organoplatinum Compounds [administration & dosage]; 7. Randomized Controlled Trials as Topic; 8. Survival Analysis; 9. Topotecan [administration & dosage]; | Provide MESH terms for the study
Chemotherapy versus best supportive care for extensive small cell lung cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Breast Neoplasms [*radiotherapy, surgery]; 2. Carcinoma in Situ [*radiotherapy, surgery]; 3. Carcinoma, Ductal, Breast [*radiotherapy, surgery]; 4. Combined Modality Therapy [methods]; 5. Mastectomy, Segmental; 6. Radiotherapy [adverse effects]; 7. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Post‐operative radiotherapy for ductal carcinoma in situ of the breast | You are a research assistant. Based on the question please provide appropriate answers |
1. Follow-Up Studies; 2. Genital Neoplasms, Female [*therapy]; 3. *Outcome Assessment, Health Care; 4. *Self Report; | Provide MESH terms for the study
Patient‐reported outcome measures for follow‐up after gynaecological cancer treatment | You are a research assistant. Based on the question please provide appropriate answers |
1. Antibiotics, Antineoplastic [*therapeutic use]; 2. Antineoplastic Combined Chemotherapy Protocols [*therapeutic use]; 3. Carboplatin [administration & dosage]; 4. Carcinoma, Ovarian Epithelial; 5. Doxorubicin [*analogs & derivatives, therapeutic use]; 6. Drug Administration Schedule; 7. Neoplasms, Glandular and Epithelial [*drug therapy]; 8. Ovarian Neoplasms [*drug therapy]; 9. Paclitaxel [administration & dosage]; 10. Polyethylene Glycols [therapeutic use]; 11. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Pegylated liposomal doxorubicin for first‐line treatment of epithelial ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Oral; 2. Anti-Bacterial Agents [*administration & dosage, adverse effects]; 3. Chemotherapy-Induced Febrile Neutropenia [*drug therapy, mortality]; 4. Injections, Intravenous; 5. Neoplasms [*drug therapy]; 6. Randomized Controlled Trials as Topic; 7. Treatment Failure; | Provide MESH terms for the study
Oral versus intravenous antibiotic treatment for febrile neutropenia in cancer patients | You are a research assistant. Based on the question please provide appropriate answers |
1. Hysterectomy [*methods]; 2. Hysterectomy, Vaginal [methods]; 3. Laparoscopy [*methods]; 4. Neoplasm Staging; 5. Randomized Controlled Trials as Topic; 6. Uterine Cervical Neoplasms [pathology, *surgery]; | Provide MESH terms for the study
Laparoscopically assisted radical vaginal hysterectomy versus radical abdominal hysterectomy for the treatment of early cervical cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Elective Surgical Procedures; 2. Fluid Therapy [*methods]; 3. *Food; 4. Malnutrition [*diet therapy, etiology]; 5. Ovarian Neoplasms [complications, *surgery]; 6. Perioperative Care [*methods]; 7. Postoperative Nausea and Vomiting [epidemiology]; 8. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Perioperative nutrition interventions for women with ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Catheter Ablation [*methods]; 2. Complex Regional Pain Syndromes [*therapy]; 3. Leg [innervation]; 4. Neck; 5. Neuralgia [*therapy]; 6. Phenol; 7. Randomized Controlled Trials as Topic; 8. Sympathectomy [*methods]; 9. Sympathectomy, Chemical [methods]; 10. Sympatholytics; 11. Thorax; | Provide MESH terms for the study
Cervico‐thoracic or lumbar sympathectomy for neuropathic pain and complex regional pain syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Depression [*therapy]; 2. Head and Neck Neoplasms [*psychology]; 3. *Quality of Life; 4. Randomized Controlled Trials as Topic; 5. Stress, Psychological [*therapy]; 6. Surveys and Questionnaires; | Provide MESH terms for the study
Psychosocial interventions for patients with head and neck cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*therapeutic use]; 2. Disease-Free Survival; 3. Maintenance Chemotherapy [adverse effects, *methods]; 4. Ovarian Neoplasms [*drug therapy, mortality, radiotherapy]; 5. Quality of Life; 6. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Maintenance chemotherapy for ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Aminoglycosides [adverse effects, *therapeutic use]; 2. Anti‐Bacterial Agents [*therapeutic use]; 3. Cause of Death; 4. Combined Modality Therapy [adverse effects, methods]; 5. Neoplasms [*complications]; 6. Neutropenia [*drug therapy, mortality]; 7. Randomized Controlled Trials as Topic; 8. beta‐Lactams [*therapeutic use]; | Provide MESH terms for the study
Beta‐lactam versus beta‐lactam‐aminoglycoside combination therapy in cancer patients with neutropenia | You are a research assistant. Based on the question please provide appropriate answers |
1. *Cryotherapy; 2. *Neoplasm Recurrence, Local; 3. Aminolevulinic Acid [analogs & derivatives, therapeutic use]; 4. Aminoquinolines [therapeutic use]; 5. Antineoplastic Agents [*therapeutic use]; 6. Bowen's Disease [*therapy]; 7. Fluorouracil [therapeutic use]; 8. Imiquimod; 9. Photochemotherapy [*methods]; 10. Photosensitizing Agents [*therapeutic use]; 11. Skin Neoplasms [*therapy]; 12. Treatment Outcome; | Provide MESH terms for the study
Interventions for cutaneous Bowen's disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [*therapeutic use]; 2. Chemotherapy, Adjuvant [methods, mortality]; 3. Disease‐Free Survival; 4. Interferon‐alpha [*therapeutic use]; 5. Melanoma [*drug therapy, mortality, surgery]; 6. Randomized Controlled Trials as Topic; 7. Skin Neoplasms [*drug therapy, mortality, surgery]; | Provide MESH terms for the study
Interferon alpha for the adjuvant treatment of cutaneous melanoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Attitude to Death; 2. *Caregivers; 3. Cost-Benefit Analysis; 4. Critical Illness [*nursing]; 5. *Home Care Services [economics]; 6. Palliative Care [economics, *methods]; 7. Patient Preference; 8. Randomized Controlled Trials as Topic; 9. Treatment Outcome; | Provide MESH terms for the study
Effectiveness and cost‐effectiveness of home palliative care services for adults with advanced illness and their caregivers | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents [adverse effects, *therapeutic use]; 2. Carcinoma, Ovarian Epithelial; 3. Disease‐Free Survival; 4. Interferons [adverse effects, *therapeutic use]; 5. Neoplasms, Glandular and Epithelial [*drug therapy, mortality, pathology, surgery]; 6. Ovarian Neoplasms [*drug therapy, mortality, pathology, surgery]; | Provide MESH terms for the study
Interferon after surgery for women with advanced (Stage II‐IV) epithelial ovarian cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Axilla; 2. Breast Neoplasms [*surgery]; 3. Fibrin Tissue Adhesive [*administration & dosage]; 4. Hemostatics [*administration & dosage]; 5. Lymph Node Excision [*adverse effects]; 6. Postoperative Complications [*prevention & control]; 7. Randomized Controlled Trials as Topic; 8. Seroma [*prevention & control]; 9. *Surgical Flaps; 10. Treatment Failure; | Provide MESH terms for the study
Fibrin glue instillation under skin flaps to prevent seroma‐related morbidity following breast and axillary surgery | You are a research assistant. Based on the question please provide appropriate answers |
1. Anemia [etiology]; 2. Breast Neoplasms [*drug therapy, mortality, *radiotherapy, surgery]; 3. Chemotherapy, Adjuvant [adverse effects, *methods]; 4. Pigmentation Disorders [etiology]; 5. Radiotherapy, Adjuvant [adverse effects, *methods]; 6. Randomized Controlled Trials as Topic; 7. Telangiectasis [etiology]; 8. Time Factors; | Provide MESH terms for the study
Sequencing of chemotherapy and radiotherapy for early breast cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Antineoplastic Agents, Alkylating [*therapeutic use]; 3. Brain Neoplasms [*drug therapy, pathology, radiotherapy]; 4. Dacarbazine [*analogs & derivatives, therapeutic use]; 5. Glioblastoma [*drug therapy, pathology, radiotherapy]; 6. Neoplasm Grading; 7. Neoplasm Recurrence, Local [drug therapy]; 8. Randomized Controlled Trials as Topic; 9. Survival Analysis; 10. Temozolomide; | Provide MESH terms for the study
Temozolomide for high grade glioma | You are a research assistant. Based on the question please provide appropriate answers |
1. Acquired Immunodeficiency Syndrome [complications]; 2. Anorexia [*drug therapy, etiology]; 3. Appetite Stimulants [adverse effects, *therapeutic use]; 4. Cachexia [*drug therapy, etiology]; 5. Megestrol Acetate [adverse effects, *therapeutic use]; 6. Neoplasms [complications]; 7. Randomized Controlled Trials as Topic; 8. Syndrome; | Provide MESH terms for the study
Megestrol acetate for treatment of anorexia‐cachexia syndrome | You are a research assistant. Based on the question please provide appropriate answers |
1. Aorta, Abdominal; 2. Disease-Free Survival; 3. Lymph Node Excision [adverse effects]; 4. Lymph Nodes [*pathology, surgery]; 5. Lymphatic Metastasis; 6. Magnetic Resonance Imaging; 7. Neoplasm Staging [*methods]; 8. Randomized Controlled Trials as Topic; 9. Tomography, X-Ray Computed; 10. Uterine Cervical Neoplasms [*pathology, radiotherapy, surgery]; | Provide MESH terms for the study
Pre‐treatment surgical para‐aortic lymph node assessment in locally advanced cervical cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. *Health Status; 2. *Program Evaluation; 3. *Survivors [psychology]; 4. Neoplasms [psychology, *rehabilitation]; 5. Randomized Controlled Trials as Topic; 6. Treatment Outcome; | Provide MESH terms for the study
Multidimensional rehabilitation programmes for adult cancer survivors | You are a research assistant. Based on the question please provide appropriate answers |
1. Antineoplastic Agents, Alkylating [therapeutic use]; 2. Carcinosarcoma [*drug therapy, mortality, *radiotherapy, surgery]; 3. Chemotherapy, Adjuvant; 4. Ifosfamide [therapeutic use]; 5. Paclitaxel [therapeutic use]; 6. Radiotherapy [adverse effects, methods]; 7. Radiotherapy, Adjuvant; 8. Randomized Controlled Trials as Topic; 9. Uterine Neoplasms [*drug therapy, mortality, *radiotherapy, surgery]; | Provide MESH terms for the study
Adjuvant radiotherapy and/or chemotherapy after surgery for uterine carcinosarcoma | You are a research assistant. Based on the question please provide appropriate answers |
1. Age Factors; 2. Antineoplastic Agents [administration & dosage, adverse effects]; 3. Antineoplastic Combined Chemotherapy Protocols [adverse effects, *therapeutic use]; 4. Cisplatin [administration & dosage, adverse effects]; 5. Neoplasm Recurrence, Local [*drug therapy]; 6. Paclitaxel [administration & dosage]; 7. Uterine Cervical Neoplasms [*drug therapy, pathology]; | Provide MESH terms for the study
Chemotherapy for metastatic and recurrent cervical cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Anxiety [*prevention & control]; 2. Colposcopy [adverse effects, *psychology]; 3. Microscopy, Video; 4. Music Therapy; 5. Pain [etiology]; 6. Pain Measurement [methods]; 7. Pamphlets; 8. Patient Education as Topic; 9. Randomized Controlled Trials as Topic; 10. Uterine Cervical Neoplasms [diagnosis, psychology]; | Provide MESH terms for the study
Interventions for reducing anxiety in women undergoing colposcopy | You are a research assistant. Based on the question please provide appropriate answers |
1. Neoplasm Recurrence, Local [*drug therapy, pathology]; 2. Neoplasm Staging; 3. Neoplasms, Germ Cell and Embryonal [*drug therapy, pathology]; 4. Ovarian Neoplasms [*drug therapy, pathology]; 5. Randomized Controlled Trials as Topic; 6. Retrospective Studies; | Provide MESH terms for the study
Chemotherapy for malignant germ cell ovarian cancer in adult patients with early stage, advanced and recurrent disease | You are a research assistant. Based on the question please provide appropriate answers |
1. Carcinoma, Non‐Small‐Cell Lung [*drug therapy, mortality, *surgery]; 2. Chemotherapy, Adjuvant; 3. Lung Neoplasms [*drug therapy, mortality, *surgery]; 4. Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Chemotherapy and surgery versus surgery alone in non‐small cell lung cancer | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Topical; 2. Adrenal Cortex Hormones [administration & dosage, therapeutic use]; 3. *Anti-Inflammatory Agents [administration & dosage, therapeutic use]; 4. Bias; 5. *Eczema [drug therapy]; 6. Emollients [therapeutic use]; 7. *Network Meta-Analysis; 8. Quality of Life; 9. *Randomized Controlled Trials as Topic; | Provide MESH terms for the study
Topical anti‐inflammatory treatments for eczema: network meta‐analysis | You are a research assistant. Based on the question please provide appropriate answers |
1. Bias; 2. *High-Frequency Ventilation [methods]; 3. *Infant, Premature; 4. Intubation, Intratracheal [methods]; 5. *Noninvasive Ventilation [methods]; 6. Pulmonary Surfactants [therapeutic use]; 7. *Randomized Controlled Trials as Topic; 8. *Respiratory Distress Syndrome, Newborn [mortality, therapy]; | Provide MESH terms for the study
Non‐invasive high‐frequency ventilation in newborn infants with respiratory distress | You are a research assistant. Based on the question please provide appropriate answers |
1. Bangladesh; 2. *Cholera [prevention & control]; 3. *Cholera Vaccines; 4. Diarrhea; 5. Vaccination; 6. Vaccines, Inactivated [adverse effects]; | Provide MESH terms for the study
Oral killed cholera vaccines for preventing cholera | You are a research assistant. Based on the question please provide appropriate answers |
1. Administration, Intranasal; 2. Adrenal Cortex Hormones [therapeutic use]; 3. *Anti-Bacterial Agents [therapeutic use]; 4. *Otitis Media with Effusion [drug therapy]; 5. Steroids [adverse effects]; | Provide MESH terms for the study
Topical and oral steroids for otitis media with effusion (OME) in children | You are a research assistant. Based on the question please provide appropriate answers |
1. *Developing Countries; 2. Health Education; 3. Immunization; 4. Randomized Controlled Trials as Topic; 5. Vaccination; 6. *Vaccines; | Provide MESH terms for the study
Interventions for improving coverage of childhood immunisation in low‐ and middle‐income countries | You are a research assistant. Based on the question please provide appropriate answers |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.